Pascal Biosciences
iStock_000025265429Small.jpg

Leadership

Leadership

Patrick W. Gray, PhD, CEO and President

pat

Dr. Gray has spent 35 years in the biotechnology industry, focusing on drug discovery for critical diseases. He has a passion for working in small companies with aggressive timelines—Genentech, ICOS, Macrogenics, Nura and Accelerator were all less than 60 employees when he joined. Dr. Gray’s career accomplishments include the first cloning and characterization of Hepatitis B surface antigen, Interferon-gamma, multiple Interferon-alpha genes, Lymphotoxin (TNF-beta), Bactericidal Permeability Increasing Protein, LPS-Binding Protein, Platelet Activating Factor Acetylhydrolase, CCR5 (subsequently shown to be the HIV co- receptor), Macrophage Derived Chemokine, and PI3K p110-delta. These discoveries led to numerous clinical trials, several approved human pharmaceuticals, and characterization of targets for therapeutic monoclonal antibodies and small molecules. In addition to his scientific accomplishments, Dr. Gray previously held senior scientific management positions, including Vice President, Chief Scientific Officer, and CEO. Dr. Gray received his PhD in Chemistry from the University of Colorado and his BS in Biology from the University of Oregon. He is currently an affiliate professor at the University of Washington.

Judi Dalling, LLB, CFO

pat

Judi Dalling is a retired lawyer with experience in corporate and securities law. She also has a strong accounting background, having been controller and business manager of a major magazine publishing enterprise for over 20 years. Ms. Dalling currently works with various reporting companies, providing legal, accounting and administration services.





Wilfred Jefferies, PhD, Founding Scientist

pat

Dr. Jefferies is a Professor at the University of British Columbia and is the scientific founder of the Company. He previously founded Synapse Technologies Inc., which was subsequently acquired by BioMarin Pharmaceuticals Inc. A world expert in identifying biomarkers of Alzheimer’s disease and the delivery of drugs across the blood brain barrier. Dr. Jefferies holds a BS in Biochemistry from the University of Victoria and a PhD from the Sir William Dunn School of Pathology at the University of Oxford. He is a Professor in the Michael Smith Laboratories at the University of British Columbia.